Chromogranin A, a Marker of the Therapeutic Success of Resection of Neuroendocrine Liver Metastases:...
Chromogranin A, a Marker of the Therapeutic Success of Resection of Neuroendocrine Liver Metastases: Preliminary Report
About this item
Full title
Author / Creator
Publisher
New York: Springer‐Verlag
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer‐Verlag
Subjects
More information
Scope and Contents
Contents
Recent publications indicate that life may be prolonged by surgical debulking of neuroendocrine tumors. A minimum 90% reduction of liver metastases has been suggested to alleviate symptoms of the carcinoid. We have used the tumor marker chromogranin A (CgA) to assess hepatic resection in patients with neuroendocrine metastatic tumor disease. Since...
Alternative Titles
Full title
Chromogranin A, a Marker of the Therapeutic Success of Resection of Neuroendocrine Liver Metastases: Preliminary Report
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_67166926
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67166926
Other Identifiers
ISSN
0364-2313
E-ISSN
1432-2323
DOI
10.1007/s00268-004-7384-6
